Registered Kenya · PPB

PNEUMORAL TABLETS

FENSPIRIDE

586 80MG respiratory system INN generic

What it does

Fenspiride is a medication used to relieve symptoms of respiratory conditions.

Commonly used for: cough, respiratory infections, bronchitis

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
586
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FENSPIRIDE
Dosage form
80MG
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
R03BX - Other drugs for obstructive airway diseases, inhalants
Drug group
RESPIRATORY SYSTEM
RxNorm RxCUI
4335
Manufacturer / MAH
Harleys
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
63 Westlands Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:51:45 · updated 2026-07-26 11:42:15

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fenspiride is a medication used to relieve symptoms of respiratory conditions.

What it treats

  • cough
  • respiratory infections
  • bronchitis

How it works

Fenspiride works by reducing inflammation in the airways and helping to ease coughing.

Who it's for

Fenspiride is suitable for adults and children who are experiencing persistent coughing due to respiratory issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fenspiride

BNF-referenced

Fenspiride is a drug primarily used for its anti-inflammatory and bronchodilator properties. It is indicated for the treatment of respiratory conditions characterized by bronchospasm and inflammation, such as asthma and chronic obstructive pulmonary disease (COPD). Fenspiride works by acting on the respiratory tract, providing symptomatic relief from cough and bronchial hyperreactivity.

Indications

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchitis
  • Respiratory tract infections with cough

Dosage

Children: Refer to the BNF for Children for specific dosing information.

Adults: Refer to the BNF for specific dosing information.

Mechanism of action

Fenspiride exhibits its pharmacological effects through the inhibition of inflammatory mediators and has bronchodilator activity. It is believed to modulate the release of histamine and other inflammatory cytokines, thereby reducing bronchial inflammation and facilitating easier breathing. The specific pathways involved include the blockade of certain receptors associated with allergic responses and inflammation.

Pharmacodynamics

Fenspiride demonstrates anti-inflammatory effects through the inhibition of leukotriene synthesis and the modulation of immune cell activity in the airways. This results in reduced bronchoconstriction and improved airflow. The drug’s bronchodilatory effect is primarily achieved through the relaxation of smooth muscles in the bronchial passages, alleviating symptoms of wheezing and shortness of breath.

Pharmacokinetics

Fenspiride is well-absorbed from the gastrointestinal tract following oral administration. It undergoes extensive hepatic metabolism, leading to the formation of various metabolites. The drug has a moderate half-life, which supports its dosing regimen. Renal excretion plays a role in the elimination of fenspiride and its metabolites, necessitating caution in patients with renal impairment.

Contra-indications

  • Hypersensitivity to fenspiride or any of its components
  • History of asthma exacerbation with beta-adrenergic agonists

Adverse effects

  • Drowsiness
  • Nausea
  • Vomiting
  • Allergic reactions (e.g., rash, pruritus)
  • Gastrointestinal disturbances

Interactions

  • May enhance the sedative effects of central nervous system depressants
  • Caution with concomitant use of other medications that cause drowsiness

Precautions

  • Use with caution in patients with liver impairment
  • Caution in patients with a history of seizures
  • Monitor for signs of hypersensitivity reactions

Pregnancy

Limited data on the safety of fenspiride during pregnancy. Use only if clearly needed and potential benefits justify the risks.

Breast-feeding

Data not available. Caution is advised, and breastfeeding should be avoided if the mother is taking fenspiride.

Storage

Store at room temperature, away from moisture and light. Keep out of reach of children.

Formulations

  • Tablets
  • Syrup

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: fenspiride

PubChem CID 3344

Molecular formula: C15H20N2O2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.